Overview

DNA repair describes the ensemble of cellular mechanisms that detect, signal and correct damage to the deoxyribonucleic acid (DNA) molecule. Damage occurs continually as a consequence of normal metabolism and from environmental insults such as ultraviolet light, ionizing radiation and chemical mutagens. Cells combine accurate, high-fidelity pathways with damage-tolerance strategies to preserve genome integrity, ensure faithful transmission of genetic information and protect against malignant transformation.

Sources and types of DNA damage

DNA is subject to many chemical and structural lesions. Common types include base modifications (oxidation, deamination), single-strand breaks, bulky adducts that distort the helix (for example from UV photoproducts), interstrand crosslinks and double-strand breaks. Replication errors can leave mismatches or small insertions and deletions. The frequency and mix of lesions depend on cell type, metabolic state and environmental exposures, and range broadly from thousands to millions of lesions per cell per day in some estimates.

Major repair strategies

Cells employ multiple partially overlapping pathways tailored to particular lesions. Key pathways are:

  • Direct reversal — some enzymes chemically reverse specific modifications without removing the nucleotide first.
  • Base excision repair (BER) — excises and replaces single damaged bases and repairs associated single-strand breaks.
  • Nucleotide excision repair (NER) — removes bulky, helix-distorting lesions such as UV-induced cyclobutane pyrimidine dimers.
  • Mismatch repair (MMR) — corrects replication errors including base–base mismatches and short insertion/deletion loops.
  • Double-strand break repair — repaired by non-homologous end joining (NHEJ), which can be fast but error-prone, or by homologous recombination (HR), which uses a sister chromatid as template and is generally high fidelity.
  • Translesion synthesis and tolerance — specialized polymerases bypass lesions to permit replication to continue, at the risk of introducing mutations.

DNA damage detection and signaling

Beyond lesion-specific enzymes, an integrated DNA damage response (DDR) coordinates detection, signal transduction and appropriate outcomes. Sensor proteins recognize aberrant structures and activate transducer kinases such as ATM and ATR, which in turn phosphorylate effectors including checkpoint kinases and the p53 transcription factor. This network pauses the cell cycle to allow repair, coordinates repair pathway choice and, when damage is irreparable, can trigger senescence or apoptosis.

Biological consequences and human disease

Defective repair increases mutation rates and genomic instability, driving aging and cancer. Established human syndromes illustrate pathway-specific consequences: xeroderma pigmentosum (defects in NER) causes extreme ultraviolet sensitivity and skin cancer risk; Lynch syndrome (MMR defects) predisposes to colorectal and other cancers; BRCA1/BRCA2 mutations impair homologous recombination and raise breast and ovarian cancer risk; ataxia-telangiectasia involves ATM dysfunction with neurodegeneration and radiation sensitivity. Understanding these links guides screening and management.

Therapeutic and experimental relevance

Many cancer therapies exploit DNA damage or inhibit repair. Radiotherapy and some chemotherapies induce lesions that tumor cells must repair. Targeted approaches use the principle of synthetic lethality: for example, tumors with BRCA-driven HR defects are sensitive to PARP inhibitors because combined defects overwhelm cellular repair capacity. Assays to measure repair include visualization of damage foci (such as γ-H2AX), comet assays, host-cell reactivation and reporter constructs that quantify specific pathway activity.

Research, evolution and practical considerations

Repair capacity varies with cell type and age: post-mitotic cells prioritize accurate single-strand repair to maintain long-lived functions, whereas proliferating cells emphasize replication-associated pathways. From an evolutionary perspective, the balance between error-free repair and mutagenic tolerance influences genetic diversity. Ongoing research maps repair protein structures, pathway interactions and how repair choice is regulated during the cell cycle.

Further reading and resources

For accessible introductions and summaries see general overviews and molecular descriptions. Pathway diagrams and interactive resources are available at visual guides. Clinical and translational material including disease associations and therapies can be found via clinical resources and therapeutic summaries. Protocols and experimental methods are catalogued in laboratory collections and assay guides. For reviews, databases and primary literature indexes consult review collections and research databases.